首页> 美国卫生研究院文献>Scientific Reports >Intra-articular Hyaluronic Acid in Treating Knee Osteoarthritis: a PRISMA-Compliant Systematic Review of Overlapping Meta-analysis
【2h】

Intra-articular Hyaluronic Acid in Treating Knee Osteoarthritis: a PRISMA-Compliant Systematic Review of Overlapping Meta-analysis

机译:关节内透明质酸治疗膝骨性关节炎:符合PRISMA的重叠荟萃分析系统综述

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Numerous meta-analyses have been conducted aiming to compare hyaluronic acid (HA) and placebo in treating knee osteoarthritis (OA). Nevertheless, the conclusions of these meta-analyses are not in consistency. The purpose of the present study was to perform a systematic review of overlapping meta-analyses investigating the efficacy and safety of HA for Knee OA and to provide treatment recommendations through the best evidence. A systematic review was conducted based on the PRISMA guidelines. The meta-analyses and/or systematic reviews that compared HA and placebo for knee OA were identified. AMSTAR instrument was used to evaluate the methodological quality of individual study. The information of heterogeneity within each variable was fetched for the individual studies. Which meta-analyses can provide best evidence was determined according to Jadad algorithm. Twelve meta-analyses met the eligibility requirements. The Jadad decision making tool suggests that the highest quality review should be selected. As a result, a high-quality Cochrane review was included. The present systematic review of overlapping meta-analyses demonstrates that HA is an effective intervention in treating knee OA without increased risk of adverse events. Therefore, the present conclusions may help decision makers interpret and choose among discordant meta-analyses.
机译:已经进行了许多荟萃分析,旨在比较透明质酸(HA)和安慰剂在治疗膝骨关节炎(OA)中的作用。然而,这些荟萃分析的结论并不一致。本研究的目的是对重叠的荟萃分析进行系统的综述,以研究HA对膝OA的有效性和安全性,并通过最佳证据提供治疗建议。根据PRISMA指南进行了系统的审查。确定了比较HA和安慰剂对膝OA的荟萃分析和/或系统评价。使用AMSTAR仪器评估个别研究的方法学质量。为各个研究获取每个变量内的异质性信息。根据Jadad算法确定了哪些荟萃分析可以提供最佳证据。十二项荟萃分析符合资格要求。 Jadad决策工具建议应选择质量最高的审查。结果,包括了高质量的Cochrane评价。目前对重叠荟萃分析的系统评价表明,HA是治疗膝骨关节炎的有效干预措施,不会增加不良事件的风险。因此,目前的结论可能有助于决策者解释和选择不一致的荟萃分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号